Bleeding a Colonoscopy Missed: Small Bowel Tumors and Obscure GI Bleeding

Medically reviewed by Dr. Michael Kachur · Frankfurt, Germany··

The scopes came back clean. Upper endoscopy found nothing, the colonoscopy found nothing, and the hemoglobin is still sliding. That is an odd place to land, because the two tests that settle most bleeding questions have just said nothing at all. Iron goes in, the count lifts, then drifts back down. Between the duodenal bulb and the last stretch of ileum sits a long run of bowel neither scope reached. Two clean scopes and a persistent anemia is a result that should keep the search open rather than close it, and holding a search open across months is what Healz's memory does.

Category
Health Insights
Date
Reading time
11 min
Share

This post walks the workup from the top: what obscure GI bleeding means now that the term has narrowed, why the small bowel is where the source usually turns out to be, what capsule endoscopy and device-assisted enteroscopy each contribute, where CT and MR enterography fit, and which tumour types turn up.

Bleeding a Colonoscopy Missed: Small Bowel Tumors and Obscure GI Bleeding

Why two normal scopes do not end the search

Small bowel bleeding accounts for roughly 5 to 10 percent of everyone presenting with gastrointestinal bleeding (ACG clinical guideline, American Journal of Gastroenterology, 2015). The common causes live where the scopes go, so the scopes answer most cases, and the cases they do not answer read as a failed test rather than as evidence about location.

The vocabulary shifted for this reason. The 2015 ACG guideline proposed the term small bowel bleeding in place of obscure GI bleeding, because small intestine imaging and endoscopy had improved enough that a source can usually be found, and it reserved the obscure label for patients in whom a source cannot be identified anywhere in the GI tract. The old word described a failed search; the new word names an organ. A review in Gastroenterology Report (2014) states the paradox compactly: the small intestine is the least common site of GI bleeding and the commonest cause of an obscure bleed.

Ask Healz.

One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.

Two other words carry weight in the chart. Overt bleeding is bleeding someone can see, meaning melena or hematochezia. Occult bleeding is unexplained iron deficiency anemia, with or without a positive fecal occult blood test, and no visible blood. Both can come from the same lesion. The occult version drifts, because nothing happens on any single day that demands an explanation.

The guideline also allows a second look at familiar ground: repeat upper endoscopy, push enteroscopy or repeat colonoscopy can be performed if indicated before small bowel evaluation (ACG, 2015). Lesions get missed on a first pass, especially during active bleeding.

What the iron studies are actually saying

The anemia usually arrives before the bleeding does. In patients with anemia, the AGA recommends a ferritin threshold under 45 ng/mL to diagnose iron deficiency, rather than a cutoff of 15 (AGA clinical practice guideline, Gastroenterology, 2020). So a ferritin of 30 reads as normal against the lower threshold and as iron deficient against the guideline.

The AGA pathway is deliberately patient. For an uncomplicated, asymptomatic adult with iron deficiency anemia and a negative upper endoscopy and colonoscopy, the guideline suggests a trial of iron supplementation over routine video capsule endoscopy. What changes that is the response: capsule endoscopy comes into the picture for people whose anemia does not respond to iron, who have ongoing symptoms, or who have acute bleeding requiring hospitalization or transfusion (AGA, 2020).

Each of those three triggers is a statement about time, not about a value. The ferritin from February, the hemoglobin from June, the two units given in August and the iron infusion in October are the evidence, and no single one carries the case. This is where a blood test ai analyzer that reads only today's document comes up short: the finding is the slope.

How the small bowel actually gets looked at

Video capsule endoscopy is the first-line examination of the small bowel once upper and lower GI sources are excluded, and it is done before deep enteroscopy to raise the yield (ACG, 2015). ESGE agrees, recommending it first-line in suspected small-bowel bleeding and in iron deficiency anemia when small bowel evaluation is indicated (ESGE, Endoscopy 2023). The capsule sees the mucosa along the whole length and has no therapeutic ability at all, which is its honest limitation.

Device-assisted enteroscopy is the arm that can act. Double-balloon, single-balloon and spiral enteroscopy all reach deep into the small bowel and all carry diagnostic and therapeutic potential (Gastroenterology Report, 2014), which is why ESGE recommends it to confirm and possibly treat lesions the capsule identified. ACG puts deep enteroscopy first in two situations instead: massive hemorrhage, and any case where the capsule is contraindicated.

Cross-sectional imaging answers a different question. CT enterography should be performed if the capsule is negative, and it has higher sensitivity for mural-based masses (ACG, 2015). CT is generally preferred over MR, with MR enterography an option in younger patients, and in brisk active overt bleeding CT angiography is preferred over enterography. A Meckel's scan can be considered in younger patients with overt bleeding and a normal capsule and enterography. Where obstructive symptoms or a known stenosis are on the chart, ESGE recommends cross-sectional imaging first, because capsule retention is the main adverse event in a narrowed bowel.

One quiet detail changes sequencing. Capsule endoscopy has lower detection rates in the duodenum and proximal jejunum, so push enteroscopy is used when a proximal lesion is suspected (ACG, 2015). A negative capsule is not equally negative along the whole length.

The tumour types that turn up, and why they are easy to walk past

Across capsule endoscopy series the findings sort into a predictable order: angioectasias around 50 percent, inflammation 26.8 percent and tumours 8.8 percent, per a review in Gastroenterology and Hepatology (2017). The Gastroenterology Report review (2014) calls tumours the second most common cause of small bowel bleeding at 5 to 10 percent of cases, and in the same breath an uncommon cause of GI bleeding overall. Both are true, and the tension between them is the clinical problem: common enough to be worth excluding, rare enough that nobody expects it.

The NCI groups primary small intestine cancers into adenocarcinoma, sarcoma, neuroendocrine tumors, gastrointestinal stromal tumor and lymphoma (NCI PDQ). Adenocarcinoma is the most common, roughly 25 to 50 percent of primary malignant small intestine tumours, and most occur in the duodenum. Neuroendocrine tumors make up about 20 percent of malignant small intestine lesions, occur more often in the ileum, and may be multiple, a detail our guide to carcinoid and neuroendocrine tumors takes further. GIST arises from the interstitial cells of Cajal and can occur anywhere in the bowel. Leiomyosarcoma occurs most often in the ileum, and lymphoma is uncommon as a solitary small intestine lesion.

SEER estimates 14,450 new US small intestine cancer cases and 2,170 deaths for 2026, which is 0.7 percent of all new cancer diagnoses, with a median age at diagnosis of 66 and 5-year relative survival of 71.8 percent for 2016 to 2022. The signs NCI lists are unglamorous: abdominal pain or cramps, weight loss with no known reason, a lump in the abdomen, blood in the stool.

Masses are also the lesion type the capsule handles worst. A review cites a miss rate near 19 percent for solitary small bowel lesions including tumours (Gastroenterology and Hepatology, 2017), and in one longitudinal comparison CT enterography detected small bowel tumours far more often than the capsule did. A multicentre Korean series of 79 proven small bowel tumours found the tumour missed in 9 of 54 patients who had a capsule (16.7 percent), mostly in the proximal jejunum (Gastroenterology Research and Practice, 2015). That series found anemia in 57 percent of patients with a mean hemoglobin of 10.1 g/dL, which is the shape of the presentation: quiet, not dramatic. Reading the resected specimen afterwards runs on the vocabulary our walkthrough of a colon polyp pathology report covers, margins and grade and depth of invasion.

What age does to the odds

The same clean scopes mean different things at 32 and at 72. In patients under 40, tumours, Meckel's diverticulum, Dieulafoy's lesion and Crohn's disease are the common causes (Gastroenterology Report, 2014). In older patients vascular anomalies lead, with NSAID-induced small bowel lesions also common in the elderly. That review reports vascular anomalies at 34.82 percent and small intestinal tumours at 31.25 percent in the 41 to 64 group, so the middle decades are where the two explanations sit closest together.

Angioectasia explains a great deal of small bowel bleeding, so in an older patient with a vascular lesion already found, the search can reasonably rest there. A younger patient with identical numbers carries a different prior, which is part of why the guidelines keep enterography in the pathway after a negative capsule.

How Healz reads the iron studies and the two clean scopes as one trend

The iron studies, the transfusion history and the two normal scopes arrive as separate documents, from separate visits, often in separate portals, and the finding appears only when they are read as one line. Healz is equipped with memory: it pulls the medical facts out of every upload, keeps the abnormal values up front, dates each finding and connects them across months, so the ferritin from February sits beside the hemoglobin from June and the transfusion from August.

The rest of the case sits in the same chat: one place, not ten apps. Frontier AI works the whole file. As an ai lab report reader it takes the CBC, the iron panel, the capsule report, the enterography report and a pathology report in one thread rather than one page at a time. Healz is also equipped with root-cause technology, which is why it does not stop at the first label: it asks what a rushed visit skips, cross-checks the case against more than a million rare cases, and keeps open what a negative result leaves behind, such as whether cross-sectional imaging has been done at all. You can bring a board-certified doctor into the same chat for a second opinion.

Frequently asked questions

Can a colonoscopy miss a bleeding tumor?

A colonoscopy examines the colon and usually the last part of the ileum, so most of the small intestine is outside its reach. When upper endoscopy and colonoscopy are both normal and bleeding continues, a small bowel source should be considered (ACG, 2015). The same guideline allows a second-look endoscopy first, because lesions get missed on a first pass.

What does obscure GI bleeding mean?

Since 2015 the ACG has reserved the term for cases where no source can be identified anywhere in the GI tract, and recommends calling the rest small bowel bleeding. The change followed improvements in capsule endoscopy, deep enteroscopy and cross-sectional imaging, which find a source in most people. Both labels still appear side by side in reports and papers.

What test looks at the small bowel after a normal endoscopy and colonoscopy?

Video capsule endoscopy is the first-line small bowel examination in both the ACG (2015) and ESGE (Endoscopy 2023) guidelines, and it comes before deep enteroscopy. CT enterography follows a negative capsule and has higher sensitivity for mural-based masses. Double-balloon, single-balloon and spiral enteroscopy can treat a lesion as well as find it, which the capsule cannot.

Can a capsule endoscopy miss a small bowel tumor?

Yes, and masses are the lesion type it misses most. One review cites a miss rate near 19 percent for solitary small bowel lesions including tumours (Gastroenterology and Hepatology, 2017), and a multicentre series found 16.7 percent of proven tumours missed, mostly in the proximal jejunum (Gastroenterology Research and Practice, 2015). That is why guidelines put CT enterography after a negative capsule.

Clean scopes are an answer about two organs, not a verdict on the whole gut, and an anemia that keeps returning is the record asking for the rest of the search to stay open.

Written by Healz Team · Filed under Health Insights

Your health deserves more than guesswork

Get a real investigation, not a symptom list. Root causes found, history remembered, dots connected.

Not a medical provider. Healz.ai is an educational service. Always discuss every decision with your doctor. AI can make mistakes.

© 2026 HealzAI Inc1111B S Governors Ave #92123, Dover, DE 19904, USAMade with for better health